Mapping of the C3d Receptor (CR2)-binding Site and a Neoantigenic Site in the C3d Domain of the Third Component of Complement

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1985 Jun 1

PMID 2408276

Citations 24

Authors

J D Lambris

V S Ganu

S Hirani

H J MULLER-EBERHARD

Affiliations

Soon will be listed here.

Abstract

The C3d domain of C3 contains the site that binds to the C3d receptor (CR2) which is expressed on B lymphocytes. It also contains a neoantigenic determinant that is recognized by monoclonal antibody (mAb) 130 and is expressed when C3b is cleaved to iC3b and subsequently to C3dg or C3d. mAb 130 inhibits the binding of C3d to CR2. In this study, the locations of the CR2-binding site and of the neoantigen recognized by mAb 130 within the C3d domain were investigated. Treatment of human C3d with CNBr generated two major fragments with Mrs of 12,500 and 8600. Binding studies showed that only the Mr 8600 fragment was capable of binding to both CR2 and mAb 130. Amino-terminal sequence analysis of the Mr 8600 fragment and comparison with the amino acid sequence derived from human C3 cDNA [de Bruijn, M. H. L. & Fey, G. H. (1985) Proc. Natl. Acad. Sci. USA 82, 708-712] placed it between residues 1199 and 1274 of the C3 sequence. Several peptides were synthesized according to the derived C3 sequence of amino acid residues 1209-1236. Based on their differential binding to CR2 and mAb 130, we localized the CR2-binding site and mAb 130 neoantigenic site, respectively, to residues 1227-1232 and 1217-1232 of the C3 sequence.

Citing Articles

C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells.

De Groot A, Ross T, Levitz L, Messitt T, Tassone R, Boyle C Immunol Cell Biol. 2014; 93(2):189-97.

PMID: 25385064 PMC: 4323994. DOI: 10.1038/icb.2014.89.

A new DNA vaccine fused with the C3d-p28 induces a Th2 immune response against amyloid-beta.

Guo W, Sha S, Jiang T, Xing X, Cao Y Neural Regen Res. 2014; 8(27):2581-90.

PMID: 25206569 PMC: 4145937. DOI: 10.3969/j.issn.1673-5374.2013.27.010.

Advances in understanding the structure, function, and mechanism of the SCIN and Efb families of Staphylococcal immune evasion proteins.

Garcia B, Ramyar K, Ricklin D, Lambris J, Geisbrecht B Adv Exp Med Biol. 2011; 946:113-33.

PMID: 21948365 PMC: 3422867. DOI: 10.1007/978-1-4614-0106-3_7.

Fusion to chicken C3d enhances the immunogenicity of the M2 protein of avian influenza virus.

Zhang Z, Li Y, Xu S, Chen F, Zhang L, Jiang B Virol J. 2010; 7:89.

PMID: 20459691 PMC: 2887435. DOI: 10.1186/1743-422X-7-89.

Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.

Lin J, Cherng J, Hung M, Baltina L, Baltina L, Kondratenko R Antiviral Res. 2008; 79(1):6-11.

PMID: 18423902 PMC: 7114209. DOI: 10.1016/j.antiviral.2008.01.160.

References

McCONAHEY P, Dixon F . A method of trace iodination of proteins for immunologic studies. Int Arch Allergy Appl Immunol. 1966; 29(2):185-9. DOI: 10.1159/000229699. View

Weigle W, Goodman M, MORGAN E, Hugli T . Regulation of immune response by components of the complement cascade and their activated fragments. Springer Semin Immunopathol. 1983; 6(2-3):173-94. DOI: 10.1007/BF00205872. View

Ross G, Polley M, Rabellino E, Grey H . Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med. 1973; 138(4):798-811. PMC: 2180565. DOI: 10.1084/jem.138.4.798. View

Eden A, Miller G, NUSSENZWEIG V . Human lymphocytes bear membrane receptors for C3b and C3d. J Clin Invest. 1973; 52(12):3239-42. PMC: 302601. DOI: 10.1172/JCI107525. View

Chou P, Fasman G . Conformational parameters for amino acids in helical, beta-sheet, and random coil regions calculated from proteins. Biochemistry. 1974; 13(2):211-22. DOI: 10.1021/bi00699a001. View

Brauer A, Margolies M, Haber E . The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides. Biochemistry. 1975; 14(13):3029-35. DOI: 10.1021/bi00684a036. View

Rosen A, Gergely P, Jondal M, Klein G, Britton S . Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature. 1977; 267(5606):52-4. DOI: 10.1038/267052a0. View

Law S, Levine R . Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci U S A. 1977; 74(7):2701-5. PMC: 431252. DOI: 10.1073/pnas.74.7.2701. View

Zimmerman C, Pisano J . High-performance liquid chromatography of amino acid derivatives. Methods Enzymol. 1977; 47:45-51. DOI: 10.1016/0076-6879(77)47007-1. View

10.

Lambris J, Dobson N, Ross G . Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody. Proc Natl Acad Sci U S A. 1981; 78(3):1828-32. PMC: 319228. DOI: 10.1073/pnas.78.3.1828. View

11.

Reid K, Porter R . The proteolytic activation systems of complement. Annu Rev Biochem. 1981; 50:433-64. DOI: 10.1146/annurev.bi.50.070181.002245. View

12.

Lambris J, Ross G . Assay of membrane complement receptors (CR1 and CR2) with C3b- and C3d-coated fluorescent microspheres. J Immunol. 1982; 128(1):186-9. View

13.

Tamerius J, Pangburn M, MULLER-EBERHARD H . Selective inhibition of functional sites of cell-bound C3b by hybridoma-derived antibodies. J Immunol. 1982; 128(1):512-4. View

14.

KYTE J, Doolittle R . A simple method for displaying the hydropathic character of a protein. J Mol Biol. 1982; 157(1):105-32. DOI: 10.1016/0022-2836(82)90515-0. View

15.

Inada S, Brown E, Gaither T, HAMMER C, Takahashi T, Frank M . C3d receptors are expressed on human monocytes after in vitro cultivation. Proc Natl Acad Sci U S A. 1983; 80(8):2351-5. PMC: 393818. DOI: 10.1073/pnas.80.8.2351. View

16.

Meuth J, MORGAN E, DiSipio R, Hugli T . Suppression of T lymphocyte functions by human C3 fragments. I. Inhibition of human T cell proliferative responses by a kallikrein cleavage fragment of human iC3b. J Immunol. 1983; 130(6):2605-11. View

17.

Ross G, Newman S, Lambris J, CAIN J, LACHMANN P . Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin. J Exp Med. 1983; 158(2):334-52. PMC: 2187331. DOI: 10.1084/jem.158.2.334. View

18.

Iida K, NADLER L, NUSSENZWEIG V . Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody. J Exp Med. 1983; 158(4):1021-33. PMC: 2187368. DOI: 10.1084/jem.158.4.1021. View

19.

Tack B . The beta-Cys-gamma-Glu thiolester bond in human C3, C4, and alpha 2-macroglobulin. Springer Semin Immunopathol. 1983; 6(4):259-82. DOI: 10.1007/BF02116276. View

20.

Davis 3rd A, Harrison R, LACHMANN P . Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g. J Immunol. 1984; 132(4):1960-6. View